Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer van Houte Hans
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer van Houte Hans
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hansen Gwenn
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ring Christine
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer van Houte Hans
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer van Houte Hans
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ring Christine
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hansen Gwenn
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer SANDS ARTHUR T
Nurix Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(9.99%),Baker Bros. Advisors (GP) LLC(9.99%), etc.
Nurix Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(9.9%),Jeremy C. Green(9.9%), etc.
Nurix Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(4.9%)
Nurix Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(6.18%),Deep Track Biotechnology Master Fund, Ltd.(6.18%), etc.
Nurix Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Arthur T. Sands(5.4%)
Nurix Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(5.36%)
Nurix Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Nurix Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Morgan Stanley(6.4%)
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer van Houte Hans
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hansen Gwenn
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ring Christine
No Data